-
Most Recent
Search Results
240 results for abv
The Humira Overhang Can’t Cast a Shadow on AbbVie Stock Forever
If you’re thinking about stepping into AbbVie stock here, you’re not crazy. The challenge is simply getting everyone else to believe in ABBV stock.
Is the “AI Bubble” a Ghost Story? Here’s What the Numbers Say…
In today’s Market 360, let’s look at the numbers and see which companies are proving the AI boom is built on substance – and which…
AbbVie Inc. Is a Clear Value Play in Biotech Stocks
AbbVie stock is not bouncing back after investors bailed on it following potentially negative clinical results. For value investors, ABBV trades at a discount to…
3 Big Stock Charts: AbbVie Inc (ABBV), Wal-Mart Stores, Inc. (WMT) and Huntington Bancshares Incorporated (HBAN)
Walmart (WMT) looks to break out, while Abbvie (ABBV) struggles and Huntington Bancshares (HBAN) rests after a strong rally likely to repeat itself.
Abbott Labs Worth Less Than Its Spinoff
Abbott Laboratories’ spun-off drug business, AbbVie, is being valued at just more than $55 billion — a few billion dollars more than ABT.
3 Things Driving AbbVie Inc. Stock After Q4 Earnings Report
AbbVie Inc. (NYSE:ABBV) reported fourth-quarter and full-year earnings Friday morning, and AbbVie stock responded by jumping more than 10% in early trading. What did the…
Abbott Labs Earnings Continue to Sink ABT Stock (ABT)
Abbott Labs stock is sinking,and not just because of the overall market slump. It’s time to look elsewhere in the healthcare sector for a stock…
How AI Forecasted a Hurricane… and a 602% Trading Gain
Yesterday, I told you about The Super AI Trading Event being hosted by Keith Kaplan, CEO of TradeSmith. But today, Keith wanted me to share…
Aave Price Predictions: Where Will Robinhood Listing Take the AAVE Crypto?
Today’s move in Aave and a key Robinhood listing have resulted in a surge in interest in Aave price predictions moving forward.
Shinzo Abe’s Win Doesn’t Mean Much for Japanese Stocks
Shinzo Abe won his snap election, but four more years of Abenomics won’t fix fix Japan’s demographic problems.
AbbVie Stands to Benefit from Affluenza
With another wave of coronavirus cases hitting the U.S., AbbVie stock seems a dubious investment. Yet with the acquisition of Allergan and its Botox treatment,…
Ignore the Coronavirus Catalyst for ABBV Stock
Without a coronavirus treatment, the medical community is experimenting with repurposed drugs. In this regard, the present crisis may benefit ABBV stock. Still, AbbVie has…
6 Stock Charts to Watch After the S&P 500’s New High
The S&P 500 closed out Friday at a new high. If the index is able to keep pushing above the 1900 mark, the stock charts…
How to Survive Shark-Infested Markets
Investing in the stock market during President Donald Trump’s second term feels a bit like swimming off Amity Island – the sunny, fictional beach town…
Is AbbVie Stock An Undiscovered Cannabis Play Waiting For Some Attention?
AbbVie stock’s been fairly awful lately as its core drug is showing signs of slowing down. Yet ABBV stock should not be ignored since there’s…
Is the ‘Abe Trade’ Still in Play?
Japan’s parliamentary elections further solidified Shinzo Abe’s power and should keep the ‘Abe Trade’ alive for a while longer. But cover your behind.
The ABCs of Beta for Retirement Planning
Beta is a statistical measure of a stock’s risk relative to a benchmark index. Using it can help you pick individual stocks and also get…
Looking for Income? The ABCs of BDCs
Dividend stocks are getting frothy as yield-hungry investors throw money at them. If you’re wily, though, you can get the cash flow you need without…
Short IBM Above $163
Today could provide the short seller with an opportunity to capitalize on a pullback in IBM (NYSE: IBM) to $152.
The Three Forces Behind Gold’s Record-Breaking Rally – and Why I Expect It to Continue
There are three big forces fueling gold’s incredible run, and in today’s Market 360, I’ll explain what they are, the companies benefiting from the gold…
ABVC Stock Earnings: ABVC BioPharma Reported Results for Q2 2024
ABVC BioPharma just reported results for the second quarter of 2024.
ABVC Stock Earnings: ABVC BioPharma Reported Results for Q1 2024
ABVC BioPharma just reported results for the first quarter of 2024.
10 – 10 of 240 results
